Durham, North Carolina
United States
13
2020-08-27
13
2022-10-04
These are the the leading inventors for applications assigned to Avista Pharma Solutions, Inc.:
Avista Pharma Solutions, Inc. based in Durham, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Chemical compounds
#2 | 2020-07-30 β Patent 11,512,088 granted on 2022-11-29Synthetic process and intermediates
#3 | 2020-05-07 β Patent 10,744,136 granted on 2020-08-18Sulfonamide derivatives as JAK inhibitors
#4 | 2019-12-19 β Patent 10,570,144 granted on 2020-02-25Substituted ureas as prostaglandin EP4 receptor antagonists
#5 | 2019-09-19 β Patent 10,556,909 granted on 2020-02-11Synthetic process and intermediates
#6 | 2019-09-12 β Patent 10,772,331 granted on 2020-09-15Antiparasitic compounds
#7 | 2019-05-23 β Patent 10,807,992 granted on 2020-10-20Single enantiomer antiparasitic compounds
#8 | 2019-03-26 β Patent 10,239,885 granted on 2019-03-26Compound 1-[2-[4-(2-ethyl-6,8-dimethylimidazo[1,2-Ξ±]pyrazin-3-yl)phenyl]ethyl]-3-(p-tolylsulfonyl)urea as a prostaglandin EP4 receptor antagonist
#9 | 2019-01-03 β Patent 10,342,234 granted on 2019-07-09Antiparasitic compounds
#10 | 2018-05-03 β Patent 10,092,001 granted on 2018-10-09Antiparasitic compounds
#11 | 2017-09-14 β Patent 9,883,674 granted on 2018-02-06Antiparasitic compounds
#12 | 2016-11-10 β Patent 9,686,991 granted on 2017-06-27Antiparasitic compounds
#13 | 2016-09-29 β Patent 9,643,963 granted on 2017-05-09Antiparasitic compounds
Also check out Avista Pharma Solutions, Inc.'s (Durham, United States) applicant profile with 13 patent applications submitted.
387346 β